Scientific Reports (Jul 2021)

The role of leptospiremia and specific immune response in severe leptospirosis

  • Umaporn Limothai,
  • Nuttha Lumlertgul,
  • Phatadon Sirivongrangson,
  • Win Kulvichit,
  • Sasipha Tachaboon,
  • Janejira Dinhuzen,
  • Watchadaporn Chaisuriyong,
  • Sadudee Peerapornratana,
  • Chintana Chirathaworn,
  • Kearkiat Praditpornsilpa,
  • Somchai Eiam-Ong,
  • Kriang Tungsanga,
  • Nattachai Srisawat

DOI
https://doi.org/10.1038/s41598-021-94073-z
Journal volume & issue
Vol. 11, no. 1
pp. 1 – 9

Abstract

Read online

Abstract Leptospirosis can cause a high mortality rate, especially in severe cases. This multicenter cross-sectional study aimed to examine both host and pathogen factors that might contribute to the disease severity. A total of 217 leptospirosis patients were recruited and divided into two groups of non-severe and severe. Severe leptospirosis was defined by a modified sequential organ failure assessment (mSOFA) score of more than two or needed for mechanical ventilation support or had pulmonary hemorrhage or death. We found that leptospiremia, plasma neutrophil gelatinase-associated lipocalin (pNGAL), and interleukin 6 (IL-6) at the first day of enrollment (day 1) and microscopic agglutination test (MAT) titer at 7 days after enrollment (days 7) were significantly higher in the severe group than in the non-severe group. After adjustment for age, gender, and the days of fever, there were statistically significant associations of baseline leptospiremia level (OR 1.70, 95% CI 1.23–2.34, p = 0.001), pNGAL (OR 9.46, 95% CI 4.20–21.33, p < 0.001), and IL-6 (OR 2.82, 95% CI 1.96–4.07, p < 0.001) with the severity. In conclusion, a high leptospiremia, pNGAL, and IL-6 level at baseline were associated with severe leptospirosis.